Evidence map›Paper›PMID 18030551›Full record

ReviewWiener medizinische Wochenschrift (1946)2007

[Diagnosing fungal infections: trends and new developments].

Birgit Willinger

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Wiener medizinische Wochenschrift (1946), 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Birgit WillingerAbteilung für Klinische Mikrobiologie, Klinisches Institut für Hygiene und Medizinische Mikrobiologie, Medizinische Universität Wien, Wien, Osterreich. birgit.willinger@meduniwien.ac.at

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diagnosing fungal infections remains a problem, particularly in the immunocompromised patient. Symptoms are mostly non-specific and colonization is difficult to distinguish from invasive disease. Existing diagnostic tools often lack sensitivity. Thus, the combination of various diagnostic tools is mandatory to allow earlier diagnosis of systemic fungal infections. Microscopy, culture based methods, antigen detection and molecular techniques such as PCR may help to facilitate and accelerate the diagnosis. Sensitive and specific PCR assays to detect fungal DNA are an important part of the diagnostic approach. But extensive validation and standardization is strongly needed before PCR assays can be used in a routine laboratory.

Indexed as

Antigens, FungalDNA, FungalForecastingHumansIn Situ Hybridization, FluorescenceMicrobiological TechniquesMicroscopyMycologyMycosesOpportunistic InfectionsPolymerase Chain ReactionPredictive Value of TestsAntigens, FungalDNA, Fungal

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.